AgilePulse Needle Array Electrodes are miniature needles designed to provide superior, highly-uniform electric fields in dermal or muscular tissue as part of the AgilePulse™ in vivo Gene Delivery Electroporation System. Applications for these electrodes include intra-dermal DNA vaccine research and antibody production, cancer chemotherapy research or intra-muscular gene therapy. The miniature parallel-needle array is inserted directly into the target site for fast, reliable in vivo electroporation. The electric fields produced are the closest approximation of parallel plate electrodes, treating approximately 80% of the target area with 95% of the applied electric field. The Needle Array requires the Needle Array handle which includes the Electrode Connector cable. Several needle lengths and row spacing are available for various intra-dermal or intra-muscular applications. Needle Arrays can be used for up to 500 pulses with proper care and maintenance.

Applications

• DNA Vaccine Delivery
• Cancer Vaccine Research
• Intra-dermal Transfection
• Gene Therapy Research
• Intra-muscular Gene Delivery
• Chemotherapeutic Research

• Uniform, Reliable Electric Fields
• Miniature Needles Minimize Tissue Trauma
• Disposable, Sterile
• Medical-grade plastic and surgical steel construction
• Safety-assured design
• Multiple configurations and sizes to choose

Use of the AgilePulse HT system (formerly Cyto LVT-P) is subject to an annual license agreement between Cellectis bioresearch and the purchaser. Please contact Cellectis bioresearch cytopulse@cellectis.com for further details.

Use of the Hybrimune^® device is subject to an annual license agreement between Cellectis bioresearch and the purchaser. Please contact Cellectis bioresearch cytopulse@cellectis.com for further details.

Use of the Agile Pulse In Vivo system (formerly the DermaVax device) is not authorized for any veterinary and human therapeutic uses. Contact Cellectis therapeutics contact@cellectis-therapeutics.com for such uses.